• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[晚期各种恶性肿瘤中肿瘤标志物(组织多肽抗原和癌胚抗原)的比较评估]

[A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].

作者信息

Meregalli M, Antoniazzi V, Torchio G, Colombo E, Bocchi M, Sonzini E, Lino S

机构信息

U.S.S.L. n. 67, Ospedale S. Corona, Garbagnate Milanese.

出版信息

Minerva Med. 1989 Apr;80(4):345-7.

PMID:2725935
Abstract

Radioimmunology was used to measure serum levels of CEA (carcinoembryonic antigen) in 108 patients with a variety of different advanced malignant neoplasms and in a control group of 60 healthy subjects. TPA proved more sensitive as a tumour marker than CEA, since increased TPA was found in 76% of the cancer cases compared to 42% for CEA. No significant increase in diagnostic sensitivity was obtained by using both markers rather than PTA alone.

摘要

采用放射免疫法检测了108例患有各种不同晚期恶性肿瘤的患者以及60名健康对照者血清中的癌胚抗原(CEA)水平。组织多肽抗原(TPA)作为一种肿瘤标志物比CEA更敏感,因为在76%的癌症病例中发现TPA升高,而CEA升高的病例为42%。同时使用这两种标志物而非仅使用TPA,并未显著提高诊断敏感性。

相似文献

1
[A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].[晚期各种恶性肿瘤中肿瘤标志物(组织多肽抗原和癌胚抗原)的比较评估]
Minerva Med. 1989 Apr;80(4):345-7.
2
[Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer].[癌胚抗原、糖类抗原19-9和组织多肽抗原联合检测在结直肠癌患者中的临床评估]
Gan No Rinsho. 1988 Aug;34(9):1096-100.
3
[Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].[组织多肽抗原水平在肿瘤患者中的重要性。其与其他肿瘤标志物的相关性]
Rev Esp Oncol. 1984;31(3):409-14.
4
[Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].[泌尿生殖系统癌症患者血清组织多肽抗原(TPA)的评估]
Gan To Kagaku Ryoho. 1984 May;11(5):1078-83.
5
[New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Ann Ostet Ginecol Med Perinat. 1991 Jan-Feb;112(1):36-40.
6
Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.组织多肽抗原(TPA)和癌胚抗原(CEA)在乳腺癌中的免疫细胞化学定位差异
Cancer Detect Prev. 1983;6(1-2):193-8.
7
Serum tumor markers in colorectal cancer staging, grading, and follow-up.血清肿瘤标志物在结直肠癌分期、分级及随访中的应用
J Surg Oncol. 1996 Aug;62(4):239-44. doi: 10.1002/(SICI)1096-9098(199608)62:4<239::AID-JSO2>3.0.CO;2-7.
8
Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.癌胚抗原与组织多肽抗原联合应用于肿瘤治疗及监测
Cancer Detect Prev. 1983;6(1-2):51-9.
9
Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder.
Cancer Detect Prev. 1988;11(3-6):389-96.
10
Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.结肠肿瘤中的组织多肽抗原和癌胚抗原:血清水平及免疫组化定位
Cancer Detect Prev. 1985;8(1-2):219-26.